
Corvus Pharmaceuticals Inc (CRVS) last year’s performance of 1.50% is a clear signal for an entertaining trading season.
On Friday, Corvus Pharmaceuticals Inc (NASDAQ: CRVS) was 11.96% up from the session before settling in for the closing price of $4.85. A 52-week range